Trial Profile
Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in Stage III colon cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Apr 2013
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Colon cancer
- Focus Therapeutic Use
- 21 Nov 2011 New trial record